Patents

  1. ““Bipyridine Derivatives Useful for Chelating Ruthenium, Conjugate and Ruthenium Chelated Compromising the Same and Uses Thereof”, T. L. Mindt, M. Anderla submitted 2025 (EP25307126)
  2. “Radiolabeled Nuceolin-Targeting peptide Derivatives for Diagnostic and Therapeutic Applications in Nuclear Medicine” T. L. Mindt, T. Scheiblauer, M. Anderla submitted 2025 (N° EP25307111)
  3. “One-Step Method for Synthesizing and Radiolabeling a Symmetrical Ruthenium(II) Bis(TerPyridine) Complex” T. L. Mindt, B. Lugato submitted 2025 (N° EP25306835)
  4. “Diaza-18-Crown-6 Derivatives Useful for Chelation of Actinium, Conjugates and Actinium Chelates Compromising the Same and Uses Thereof” T. L. Mindt, G. Gasser, J. Southwell, M. Gumiela submitted 2025 (N° EP25305598)
  5. “Calixarene Derivatives Useful for Chelation of Radium, Conjugates and Radium Chelates Compromising the Same, and Uses Thereof” T. L. Mindt, G. Gasser, M. Brandt, J. Cowell 2020EP20305646.0
  6. “Minigastrin Derivatives, in Particular for Use in CCK2 Receptor Positive Tumour Diagnosis and/or Treatment” T. L. Mindt, N. M. Grob, M. Behe, R. Schibli 2017EP17192428
  7. “Multidentate Chelating Agents for Radionuclide Complexation in Diagnostics and Therapy” T. L. Mindt, G. Gasser, A. Bauman, M. Patras WO2015140212A1
  8. “Bombesin Receptor Targeting Peptide Incorporating a 1,2,3-Triazole Group in the Backbone for Preparing In Vivo Diagnostic and Therapeutic Agents” T. L. Mindt, I. Valverde WO2012/156511
  9.  “Novel 18F-labelled Folates as PET Tracers” T. Ross; T. L. Mindt; V. Groehn; R. Moser; S. Ametamey; A. P. Schubiger WO2008125615.
  10. “Folic Acid Functionalized with Histidine- or Histidine-like Metal Chelators for SPECT Applications” T. L. Mindt, C. Müller, R. Schibli, V. Groehn WO2008125618.
  11. “Preparation of Triazole Containing Metal Chelating Agents as well as Their Incorporation into Biomolecules and Their Tricarbonyl Complexes with Technetium and Rhenium” T. L. Mindt, R.  Schibli 2006P12660EP.